ND

Neelu Devi

Active Director Director DIN 09568478
DIN 09568478 First appointment Apr 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2022
Shareholding value •••• Premium profile

About Neelu Devi

Data last updated:

Neelu Devi is a Director at Wayzina Pharmaceuticals Private Limited (since 2022). The company operates in Chemicals. Wayzina Pharmaceuticals Private Limited reported revenue of ₹6.6 Lakh (FY 2025).

DIN 09568478
Primary Designation Director
Industry Chemicals
First Appointment 09 Apr 2022
Oldest Company Age 11 yrs
Largest company Wayzina Pharmaceuticals Private Limited · ₹6.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Apr 20222015₹6.6 Lakh (FY 2025)Active

Board colleagues of Neelu Devi

NameDINCompanyDesignation
Rina Kumari08096199Wayzina Pharmaceuticals Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Wayzina Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Neelu Devi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neelu Devi

Neelu Devi currently holds 1 directorship: Wayzina Pharmaceuticals Private Limited (Director, since 09 Apr 2022, revenue ₹6.6 Lakh (FY 2025)).

Neelu Devi was first appointed on 09 Apr 2022 as Director at Wayzina Pharmaceuticals Private Limited.

The current boards of Neelu Devi's companies include Rina Kumari (Wayzina Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available